Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : XOMA. Bull or Bear? -- Ignore unavailable to you. Want to Upgrade?

To: Robert K. who wrote (8171)	1/3/1999 5:17:00 PM
From: Robert K.	Respond to of 17367

Patents are not proof, but sure make for some interesting reading>>>> >>>>Read Pages 8 and 9 patent.womplex.ibm.com

To: Robert K. who wrote (8171)	1/3/1999 7:46:00 PM
From: Robert S.	Read Replies (2) \| Respond to of 17367

While BPI may prove efficacious in treating meningococcemia, a review of the many posts on this thread reveals just how far off the beaten path some of the posters here have strayed. Potential uses for BPI (as suggested by the more bullish members) range from acting as a disinfectant on walls and floors to being an additive in Pepto Bismol and Kaopectate! As always, I look forward to the "potential" uses and/or indications for BPI as conjured up by the zany zealots on this board.